Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Black History Month: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention
Black History MonthPodcast

Black History Month: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention
“Trying to realize how good we actually could be if our system were truly efficient is what Otis is all about”

February 06, 2026
Vol.52 No.05
By Robert A. Winn, Otis W. Brawley and Preston Willett
The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
PodcastThe Directors

The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
Cancer centers fund small grants to boost morale amid low paylines

January 30, 2026
Vol.52 No.04
By Paul Goldberg and Claire Marie Porter
FY26 funding package blocked in Senate after ICE shooting of Alex Pretti
Capitol Hill

FY26 funding package blocked in Senate after ICE shooting of Alex Pretti
New package—likely excluding DHS—may go back to House early next week

January 30, 2026
Vol.52 No.04
By Jacquelyn Cobb
Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology
FreeIn the Archives

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

January 23, 2026
Vol.52 No.03
By Sara Willa Ernst
With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025
Guest Editorial

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

December 19, 2025
Vol.51 No.46
By Richard J. Jones
Anthony Letai pledges to ensure stability for extramural and intramural cancer science
Conversation with The Cancer Letter

Anthony Letai pledges to ensure stability for extramural and intramural cancer science

December 05, 2025
Vol.51 No.44
By Paul Goldberg
Andres Álvarez-Pinzón, Ronald Chen, Vered Stearns, Alexandra Thomas, Trisha Wise-Drapernamed to NRG Oncology leadership
In Brief

Andres Álvarez-Pinzón, Ronald Chen, Vered Stearns, Alexandra Thomas, Trisha Wise-Drapernamed to NRG Oncology leadership

December 05, 2025
Vol.51 No.44
Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87
FreeObituary

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

November 21, 2025
Vol.51 No.43
By Donna M. O’Brien and Barnett Kramer
In Brief

Mount Sinai Tisch Cancer Center receives Comprehensive designation and funding from NCI

November 21, 2025
Vol.51 No.43
Site visits are gone, but outlook for new, centralized CCSG review is bright
Podcast

Site visits are gone, but outlook for new, centralized CCSG review is bright

November 05, 2025

Posts navigation

Previous1…345…40Next

Trending Stories

  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
    Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
  • FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
    Clinical benefit will not be considered for approval, FDA says
  • Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • The Galleri MCD vote: What FDA asked its advisors to ignore

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account